These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2534920)

  • 1. [Lupus erythematosus. 1. Systemic lupus erythematosus: historical outline, epidemiology, etiopathology, histology and pathologic anatomy].
    Frojo M; Lamparelli A; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Oct; 30(4):799-819. PubMed ID: 2534920
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus.
    Koffler D
    Sci Am; 1980 Jul; 243(1):40-9. PubMed ID: 6450445
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus.
    Wollina U
    Allerg Immunol (Leipz); 1984; 30(1):3-13. PubMed ID: 6233860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathologic anatomy & histology of generalized lupus erythematosus].
    VAN UNNIK J
    Ned Tijdschr Geneeskd; 1958 May; 102(21):978-81. PubMed ID: 13566267
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe autoimmune type V hyperlipidemia preceding a systemic lupus erythematosus in a 15 year-old girl.
    Michel M; Foïs E; Niault M; Pruneta V; Godeau B; Michel M
    Lupus; 2007; 16(5):378-9. PubMed ID: 17576743
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pan T, T4 and T8-positive lymphocytes in the peripheral blood of patients with systemic lupus erythematosus].
    Grunow R; Volk HD; von Baehr R
    Z Gesamte Inn Med; 1987 Mar; 42(5):130-4. PubMed ID: 2954308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
    Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of regulatory T cells in systemic lupus erythematosus.
    Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C
    Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells in lupus.
    Kang HK; Datta SK
    Int Rev Immunol; 2006; 25(1-2):5-25. PubMed ID: 16531276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of regulatory T cells in patients with systemic lupus erythematosus.
    Mellor-Pita S; Citores MJ; Castejon R; Tutor-Ureta P; Yebra-Bango M; Andreu JL; Vargas JA
    Ann Rheum Dis; 2006 Apr; 65(4):553-4. PubMed ID: 16531555
    [No Abstract]   [Full Text] [Related]  

  • 15. A rapidly fatal case of systemic lupus erythematosus: structures resembling viral nucleoprotein strands in the kidney and activities of lymphocytes in culture.
    Sinkovics JG; Gyorkey F; Thoma GW
    Tex Rep Biol Med; 1969; 27(3):887-908. PubMed ID: 5374267
    [No Abstract]   [Full Text] [Related]  

  • 16. SiLEncing SLE: the power and promise of small noncoding RNAs.
    Rigby RJ; Vinuesa CG
    Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symposium on immunologic disorders and their control.
    Jpn J Med; 1982 Jan; 21(1):56-70. PubMed ID: 6461791
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory T cells and systemic lupus erythematosus.
    Mudd PA; Teague BN; Farris AD
    Scand J Immunol; 2006 Sep; 64(3):211-8. PubMed ID: 16918689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell subsets in patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ
    Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.